GlaxoSmithKline buys and sells in Indonesia

31 March 2014 - Deborah Wilkes

Archived

GlaxoSmithKline has acquired the 30% stake in its Indonesian Consumer Healthcare business that it did not previously own, and is divesting the Insto eye drops brand and a manufacturing facility in the country.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: